Medicine with the Active Ingredient Cerliponase Tender - 146663281

Procurement Summary

Country: Slovakia

Summary: Medicine with the Active Ingredient Cerliponase Alfa 150 Mg, Infusion Solution Description: the Subject of the Order is Medicine with the Active Ingredient Cerliponase Alfa 150 Mg, Infusion Solution Pharmaceutical Form: Sol Inf 5 Ml/150 Mg+5 Ml...

Deadline: 10 Sep 2026

Posting Date: 06 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 146663281

Document Ref. No.: 11276 - MST

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: EUR 2678664.6

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Medicine with the active ingredient cerliponase alfa 150 mg, infusion solution Description: The subject of the order is Medicine with the active ingredient cerliponase alfa 150 mg, infusion solution Pharmaceutical form: sol inf 5 ml/150 mg+5 ml prepl. solution (inj. glass medicine) Administration: intracerebroventricular use The drug cerliponase alfa belongs to a group of drugs known as enzyme replacement therapy. It is used to treat patients with neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase 1 (TPP1) deficiency. People with with CLN2 disease, they do not have an enzyme called TPP1 or they have too little of it, which causes the accumulation of substances called lysosomal accumulation substances. In people with CLN2 disease, these substances accumulate in some parts of the body, especially in the brain. This medicine replaces the defective an enzyme called TPPA, thereby minimizing the accumulation of lysosomal storage substances. This medicine works by slowing down the progress of the disease. The recommended dose is 300 mg of cerliponase alfa, which is administered once every two weeks by intracerebroventricular infusion. Type of order: Goods 4.1.3 Scope of procurement Estimated value Estimated value (BT-27-Procedure) (value): 2, 678, 664.6 Estimated value (BT-27-Procedure) (currency): Euro Maximum value of the framework agreement Maximum value of the framework agreement (BT-271-Procedure) (value): 2, 812, 597.83 Maximum value of the framework agreement (BT-271-Procedure) (currency): Euro Main classification Classification type: Common procurement vocabulary Main CPV code: Medicines for the nutritional system and metabolism Information on additional classification of the subject of the contract Information about the additional classification of the subject of the contract Classification type: Common procurement dictionary 4.1.4 Information about the place of fulfillment Information about the place of fulfillment Street: Nam. L. Svobo...
Deadline for submission of bids: (date): 10/09/2026 Deadline for submission of bids (time): 09:00 Deadline for bids Deadline for which bids must remain binding Deadline for bids for which bids must remain binding (BT-98-Lot) (value): 4 Deadline for bids for which bids must remain binding (BT-98-Lot) (unit): Month Language of submission of bids Language of submission of bids Language in which bids can be submitted: Slovak Language of bid submission Language in which bids can be submitted: čestina Information on opening of bids Date of opening of bids: 10.09.2026 Bid opening time: 10:00 Bid opening place: electronically Method of submitting bids or requests to participate Electronic bid submission: Mandatory Address for submitting bids (URL): https://www.isepvo.sk/ Information on competition documents Information on competition materials Competition materials in official languages ​​Competition materials in official language Competition materials in official language Official language of competition materials: Slovak Restricted access to competition materials: No restrictions on access to by document Competition documents (URL): https://www.uvo.gov.sk/vyhladavanie/vyhladavanie-zakaziek/dokumenty/562736 Designation of document/contract: Competition documents Communication channel ad hoc Name of electronic means: IS EVO Review Deadlines for review Description deadline for review: Deadlines for submitting objections are governed by the valid and effective law on public procurement. Review Organization ID of the organization responsible for the review: ORG-0001 (Public Procurement Office) Organization providing information on reviews ID of the provider of information about the review: ORG-0001 (Public Procurement Office) Profile of the Purchaser Order: Medicine with the active substance cerliponase alfa 150 mg, infusion solution ...

Documents

 Tender Notice